If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAoti, Inc. Regulatory News (AOTI)

Share Price Information for Aoti, Inc. (AOTI)

Share Price is delayed by 15 minutes
Get Live Data
62.50    0.00 (0.00%)
Bid:
60.00
Ask:
65.00
Spread: 5.00 (8.333%)
Market Cap: £66.32m
AOTI Live PriceLast checked at - London Stock Exchange

Intraday Aoti, Inc. Share Chart

Holding(s) in Company

1 Aug 2025 10:03

RNS Number : 6113T
AOTI, Inc.
01 August 2025
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

US03690C1027

Issuer Name

AOTI, INC.

UK or Non-UK Issuer

Non-UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Wasatch Advisors, LP

City of registered office (if applicable)

Salt Lake City

Country of registered office (if applicable)

United States

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

31-Jul-2025

6. Date on which Issuer notified

31-Jul-2025

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

13.677000

0.000000

13.677000

14546945

Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

US03690C1027

14546945

13.677000

Sub Total 8.A

14546945

13.677000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

01-Aug-2025

13. Place Of Completion

505 Wakara Way, 3rd Floor, Salt Lake City, UT 84108

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUARKRVUUWRRR
Date   Source Headline
19th Jun 20267:00 amRNSDirector/PDMR Shareholding – Share purchase
21st May 202611:15 amRNSResult of AGM
1st May 20267:00 amRNSEmployee Share Purchase Plan
27th Apr 20267:00 amRNSReal-world study of AOTI’s TWO2® therapy
23rd Apr 20267:00 amRNSGrant of awards under Long Term Incentive Plan
21st Apr 20267:00 amRNS2025 Annual Report and Notice of AGM
30th Mar 20267:00 amRNSFinal Results
23rd Feb 20267:00 amRNSFull Year Trading Update and Notice of Results
15th Dec 202510:17 amRNSHolding(s) in Company
6th Oct 20257:00 amRNSAppointment of Joint Corporate Broker
22nd Sep 20257:00 amRNS2025 Interim Results
8th Sep 20257:00 amRNSNotice of Results
3rd Sep 20257:00 amRNSNICE fast track recommendation for Topical Oxygen
4th Aug 20257:00 amRNSDirector/PDMR Shareholding
1st Aug 202510:03 amRNSHolding(s) in Company
31st Jul 202511:02 amRNSDirector/PDMR Shareholding
31st Jul 20257:00 amRNSResults of Placing
30th Jul 20254:36 pmRNSProposed Placing in AOTI Inc.
21st Jul 20257:00 amRNSCalifornia Medicaid Provider ID Awarded
21st Jul 20257:00 amRNSHalf Year Trading and FY 2025 Guidance Update
25th Jun 20251:24 pmRNSResult of AGM
23rd Jun 20257:00 amRNSAOTI unlocks broad market access in Germany
18th Jun 20257:00 amRNSEnd of Distribution Compliance Period
27th May 20257:00 amRNS2024 Annual Report and Notice of AGM
19th May 20257:00 amRNS-RPresentation at AJ Bell and Shares Spotlight Event
13th May 20257:00 amRNSDirector Shareholding - Share Purchase
7th May 20257:00 amRNSDirector Shareholding - Share Purchase
2nd May 202511:14 amRNSDirector/PDMR Shareholding
28th Apr 20257:00 amRNS2024 Final Results
23rd Apr 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
22nd Apr 20257:00 amRNSTWO2® in NHS supply chain framework agreement
9th Apr 202510:06 amRNSNotification of Major Holdings
25th Mar 20255:59 pmRNSDirector/PDMR Shareholding
12th Feb 20257:00 amRNSTrading Update for the year ended 31 December 2024
24th Jan 20257:00 amRNSCORRECTION New Medicaid states, coverage expansion
9th Jan 20257:00 amRNSNew Medicaid states, payer coverage expansion
17th Dec 202412:00 pmRNSGrant of performance share awards under LTIP
16th Dec 20247:00 amRNSEnrolment Commences for VLU Clinical Trial
12th Dec 20247:00 amRNS5 Year Veterans Administration Contract Extension
20th Nov 202412:41 pmRNSHolding(s) in Company
11th Nov 20247:00 amRNSCMS Topical Oxygen Therapy coverage review
16th Sep 20247:00 amRNS2024 Interim Results
15th Aug 20247:00 amRNSPre-close Trading Update
29th Jul 20247:00 amRNSUS FDA 510(k) Clearance of NEXATM NPWT System
21st Jun 20242:45 pmRNSHolding(s) in Company
21st Jun 20241:41 pmRNSHolding(s) in Company
18th Jun 20247:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.